Calyx CTMS Select Delivers Robust Functionality for Small/ Mid-sized Biopharma and CROs
07.08.2025 - 18:08:16 | prnewswire.co.ukAbout Calyx
Through innovative eClinical and Regulatory solutions and services, Calyx turns the uncertain into the reliable, helping bring new medical treatments to market reliably. With deep expertise in clinical development and 30 years supporting trial sponsors and clinical research organizations, Calyx harnesses its intelligence and experience to solve complex problems, deliver fast insights, and get new drugs to market every day.
CTMS | EDC | IRT | Medical Imaging | RIM
Take your trials further with intelligent insights at Calyx.ai or at LinkedIn, Twitter, or Facebook.

Photo - https://mma.prnewswire.com/media/2280252/CALYX_Serena_Barker.jpg
Logo - https://mma.prnewswire.com/media/1396338/Calyx_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/calyx-ctms-select-delivers-robust-functionality-for-smallmid-sized-biopharma-and-cros-301992768.html
Hol dir jetzt den Wissensvorsprung der Aktien-Profis.
Für. Immer. Kostenlos.

